MiTMAB™
Cell permeable dynamin I and dynamin II inhibitorProduct Code: Asc-466 |
||||
| Pack Size | ||||
| Buy MiTMAB™ from Abcam | |||
Biological DescriptionCell permeable dynamin I and dynamin II inhibitor (IC50 = 3.1 and 8.4 µM for inhibition of dynamin I and dynamin II GTPase respectively). Targets the pleckstrin homology (PH) (lipid binding) domain. Competitive with phospholipid and noncompetitive with GTP. Inhibits receptor-mediated and synaptic vesicle endocytosis (IC50 values are 19.9 and 2.2 µM respectively). Inhibits cancer cell growth. |
|
Useful References | |
Long chain amines and long chain ammonium salts as novel inhibitors of dynamin GTPase activity. abstract Myristyl trimethyl ammonium bromide and octadecyl trimethyl ammonium bromide are surface-active small molecule dynamin inhibitors that block endocytosis mediated by dynamin I or dynamin II. abstract The dynamin inhibitors MiTMAB and OcTMAB induce cytokinesis failure and inhibit cell proliferation in human cancer cells. abstract | |
Chemical InformationTetradecyltrimethylammonium bromide | |
![]() |
|
Additional InformationSold under exclusive licence from Children's Medical Research Institute and Newcastle Innovation Ltd. MiTMAB™ is a trademark of Children's Medical Research Institute and Newcastle Innovation Ltd |
|

